Business Description
Dr. Lal PathLabs Ltd
ISIN : INE600L01024
Compare
Compare
Traded in other countries / regions
LALPATHLAB.India IPO Date
2015-12-23Description
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.11 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 0.46 | |||||
| Interest Coverage | 22.57 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 19.97 | |||||
| Beneish M-Score | -3.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.6 | |||||
| 3-Year EBITDA Growth Rate | 9.8 | |||||
| 3-Year EPS without NRI Growth Rate | 2.5 | |||||
| 3-Year FCF Growth Rate | 26 | |||||
| 3-Year Book Growth Rate | 17.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.27 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.26 | |||||
| 9-Day RSI | 49.97 | |||||
| 14-Day RSI | 51.99 | |||||
| 6-1 Month Momentum % | -11.68 | |||||
| 12-1 Month Momentum % | 18.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.29 | |||||
| Quick Ratio | 2.21 | |||||
| Cash Ratio | 1.97 | |||||
| Days Inventory | 33.26 | |||||
| Days Sales Outstanding | 13.9 | |||||
| Days Payable | 133.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.04 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| 3-Year Dividend Growth Rate | -8.2 | |||||
| Forward Dividend Yield % | 1.04 | |||||
| 5-Year Yield-on-Cost % | 3.85 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | 1.66 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.24 | |||||
| Operating Margin % | 33.04 | |||||
| Net Margin % | 15.19 | |||||
| FCF Margin % | 18.94 | |||||
| ROE % | 19.84 | |||||
| ROA % | 13.88 | |||||
| ROIC % | 30.14 | |||||
| ROC (Joel Greenblatt) % | 126.85 | |||||
| ROCE % | 26.15 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 58.5 | |||||
| PE Ratio without NRI | 58.5 | |||||
| Shiller PE Ratio | 69.52 | |||||
| Price-to-Owner-Earnings | 45 | |||||
| PEG Ratio | 3.95 | |||||
| PS Ratio | 8.88 | |||||
| PB Ratio | 10.87 | |||||
| Price-to-Tangible-Book | 21.56 | |||||
| Price-to-Free-Cash-Flow | 46.84 | |||||
| Price-to-Operating-Cash-Flow | 42.26 | |||||
| EV-to-EBIT | 37.28 | |||||
| EV-to-Forward-EBIT | 41.04 | |||||
| EV-to-EBITDA | 28.92 | |||||
| EV-to-Forward-EBITDA | 30.5 | |||||
| EV-to-Revenue | 8.59 | |||||
| EV-to-Forward-Revenue | 7.91 | |||||
| EV-to-FCF | 45.36 | |||||
| Price-to-Projected-FCF | 4.6 | |||||
| Price-to-DCF (Earnings Based) | 2.9 | |||||
| Price-to-DCF (FCF Based) | 1.97 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.3 | |||||
| Price-to-Graham-Number | 7.83 | |||||
| Price-to-Net-Current-Asset-Value | 47.5 | |||||
| Price-to-Net-Cash | 75.18 | |||||
| Earnings Yield (Greenblatt) % | 2.68 | |||||
| FCF Yield % | 2.13 | |||||
| Forward Rate of Return (Yacktman) % | 15.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dr. Lal PathLabs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 21,722 | ||
| EPS (TTM) (₹) | 39.63 | ||
| Beta | 1.05 | ||
| Volatility % | 26.51 | ||
| 14-Day RSI | 51.99 | ||
| 14-Day ATR (₹) | 55.621502 | ||
| 20-Day SMA (₹) | 2314.745 | ||
| 12-1 Month Momentum % | 18.48 | ||
| 52-Week Range (₹) | 1888.1 - 2767.1 | ||
| Shares Outstanding (Mil) | 83.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dr. Lal PathLabs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dr. Lal PathLabs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dr. Lal PathLabs Ltd Frequently Asked Questions
What is Dr. Lal PathLabs Ltd(NSE:LALPATHLAB)'s stock price today?
The current price of NSE:LALPATHLAB is ₹2318.40. The 52 week high of NSE:LALPATHLAB is ₹2767.10 and 52 week low is ₹1888.10.
When is next earnings date of Dr. Lal PathLabs Ltd(NSE:LALPATHLAB)?
The next earnings date of Dr. Lal PathLabs Ltd(NSE:LALPATHLAB) is 2024-05-31 Est..
Does Dr. Lal PathLabs Ltd(NSE:LALPATHLAB) pay dividends? If so, how much?
The Dividend Yield %  of Dr. Lal PathLabs Ltd(NSE:LALPATHLAB) is 1.04% (As of Today), Highest Dividend Payout Ratio of Dr. Lal PathLabs Ltd(NSE:LALPATHLAB) was 0.58. The lowest was 0.15. And the median was 0.34. The  Forward Dividend Yield % of Dr. Lal PathLabs Ltd(NSE:LALPATHLAB) is 1.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers